Jul 30, 2026 08:00AM
May 11, 2026 07:54AM
May 11, 2026 07:30AM
Feb 26, 2026 01:31PM
Feb 26, 2026 07:35AM
Feb 26, 2026 07:30AM
Feb 19, 2026 07:30AM Intellia Therapeutics to Hold Conference Call to Discuss Fourth Quarter and Full-Year 2025 Financial Results and Business Updates
Nov 6, 2025 04:29PM
Nov 6, 2025 04:00PM
Oct 28, 2025 04:23AM
Aug 8, 2025 06:24AM
Aug 7, 2025 07:33AM
Aug 7, 2025 07:30AM
Jul 31, 2025 07:30AM Intellia Therapeutics to Hold Conference Call to Discuss Second Quarter 2025 Earnings and Company Updates
May 8, 2025 07:31AM
May 8, 2025 07:30AM
May 1, 2025 07:30AM
Feb 27, 2025 03:04PM
Feb 27, 2025 07:30AM
Feb 27, 2025 07:30AM
Feb 20, 2025 07:30AM Intellia Therapeutics to Hold Conference Call to Discuss Fourth Quarter and Full-Year 2024 Earnings and Company Updates
Nov 11, 2024 07:52AM
Nov 7, 2024 08:21AM
Nov 7, 2024 07:30AM
Oct 31, 2024 07:30AM
Oct 7, 2024 07:31AM
Oct 7, 2024 07:30AM
Aug 8, 2024 07:30AM Intellia Therapeutics (NTLA) Misses Q2 EPS by 30c
Aug 8, 2024 07:30AM
Aug 1, 2024 07:30AM
May 9, 2024 07:37AM
May 9, 2024 07:30AM
May 2, 2024 07:30AM
Feb 23, 2024 09:23AM
Feb 22, 2024 07:37AM Intellia Therapeutics (NTLA) Misses Q4 EPS by 2c
Feb 22, 2024 07:30AM
Feb 14, 2024 07:30AM
Nov 9, 2023 07:31AM
Nov 9, 2023 07:30AM
Oct 26, 2023 07:30AM
Oct 18, 2023 07:02AM
Oct 18, 2023 07:00AM Intellia Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application to Initiate a Pivotal Phase 3 Trial of NTLA-2001 for the Treatment of Transthyretin (ATTR) Amyloidosis with
Aug 3, 2023 07:34AM
Aug 3, 2023 07:30AM
Jul 27, 2023 07:30AM
May 4, 2023 08:19AM
May 4, 2023 07:30AM
Apr 27, 2023 07:30AM
Feb 23, 2023 07:49AM Intellia Therapeutics (NTLA) Misses Q4 EPS by 2c
Feb 23, 2023 07:30AM

1,211,669 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All